FK 506 in kidney transplantation: Results of the USA randomized comparative phase III study

被引：32

作者：

Miller, J

Pirsch, JD

Deierhoi, M

Vincenti, F

Filo, RS

机构：

[1] VET ADM MED CTR, MIAMI, FL 33125 USA

[2] UNIV WISCONSIN, MADISON, WI USA

[3] UNIV ALABAMA, BIRMINGHAM, AL USA

[4] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA

[5] INDIANA UNIV, MED CTR, INDIANAPOLIS, IN USA

来源：

TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(96)00270-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：304 / 305

页数：2

共 2 条

[1] HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS [J].

MURASE, N ;

STARZL, TE ;

DEMETRIS, AJ ;

VALDIVIA, L ;

TANABE, M ;

CRAMER, D ;

MAKOWKA, L ;

BACH ;

AUCHINCLOSS ;

SOLLINGER .

TRANSPLANTATION, 1993, 55 (04) :701-708

[2] COMBINED IMMUNOSUPPRESSIVE THERAPY WITH LOW-DOSE FK506 AND ANTIMETABOLITES IN RAT ALLOGENEIC HEART-TRANSPLANTATION [J].

TANABE, M ;

TODO, S ;

MURASE, N ;

IRISH, W ;

MIYAZAWA, H ;

FUJISAKI, S ;

STARZL, TE .

TRANSPLANTATION, 1994, 58 (01) :23-27

← 1 →